Current concepts of hyperinflammation in chronic granulomatous disease

Dominik Hartl, Nikolaus Rieber, Andreas Hector, Taco Kuijpers, Dirk Roos

Research output: Contribution to journalReview articlepeer-review

113 Scopus citations

Abstract

Chronic granulomatous disease (CGD) is the most common inherited disorder of phagocytic functions, caused by genetic defects in the leukocyte nicotinamide dinucleotide phosphate (NADPH) oxidase. Consequently, CGD phagocytes are impaired in destroying phagocytosed microorganisms, rendering the patients susceptible to bacterial and fungal infections. Besides this immunodeficiency, CGD patients suffer from various autoinflammatory symptoms, such as granuloma formation in the skin or urinary tract and Crohn-like colitis. Owing to improved antimicrobial treatment strategies, the majority of CGD patients reaches adulthood, yet the autoinflammatory manifestations become more prominent by lack of causative treatment options. The underlying pathomechanisms driving hyperinflammatory reactions in CGD are poorly understood, but recent studies implicate reduced neutrophil apoptosis and efferocytosis, dysbalanced innate immune receptors, altered T-cell surface redox levels, induction of Th17 cells, the enzyme indolamine-2,3-dioxygenase (IDO), impaired Nrf2 activity, and inflammasome activation. Here we discuss immunological mechanisms of hyperinflammation and their potential therapeutic implications in CGD.

Original languageEnglish
Article number252460
JournalClinical and Developmental Immunology
Volume2012
DOIs
StatePublished - 2012
Externally publishedYes

Fingerprint

Dive into the research topics of 'Current concepts of hyperinflammation in chronic granulomatous disease'. Together they form a unique fingerprint.

Cite this